BIOC - Biocept, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPS-5.4-3.3N/AN/A
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts3032
Avg. Estimate960kN/A3.75M5M
Low Estimate800kN/A3.48M4.99M
High Estimate1.12MN/A4.16M5M
Year Ago Sales995kN/A5.07M3.75M
Sales Growth (year/est)-3.50%N/A-26.00%33.30%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.-4.95-2.55-3.3-2.02
EPS Actual-5.4-3.3-2.7-2.42
Difference-0.45-0.750.6-0.4
Surprise %-9.10%-29.40%18.20%-19.80%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate0000
7 Days Ago-1.560-9.06-5.49
30 Days Ago-1.560-9.06-5.49
60 Days Ago-1.50-9.6-5.4
90 Days Ago-1.50-9.6-5.4
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesBIOCIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.48
Next Qtr.N/AN/AN/A0.40
Current YearN/AN/AN/A0.21
Next YearN/AN/AN/A0.10
Next 5 Years (per annum)40.00%N/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A